Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer - Related Studies

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

This study has been completed.

Study NCT00028496. Last updated on October 12, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Colorectal Cancer
		Gallbladder Cancer
		Gastric Cancer
		Head and Neck Cancer
		Liver Cancer
		Ovarian Cancer
		Pancreatic Cancer
		Testicular Germ Cell Tumor

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Colorectal Neoplasms
		Gallbladder Neoplasms
		Head and Neck Neoplasms
		Liver Neoplasms
		Neoplasms, Germ Cell and Embryonal
		Ovarian Neoplasms
		Pancreatic Neoplasms
		Stomach Neoplasms

3	More general conditions related to this trial
		Adnexal Diseases
		Biliary Tract Diseases
		Biliary Tract Neoplasms
		Breast Diseases
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Gallbladder Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Genital Diseases, Female
		Genital Neoplasms, Female
		Gonadal Disorders
		Intestinal Diseases
		Intestinal Neoplasms
		Liver Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Ovarian Diseases
		Pancreatic Diseases
		Rectal Diseases
		Skin Diseases
		Stomach Diseases
		Urogenital Neoplasms

4	Interventions listed in this trial
		sargramostim

5	Sponsors listed in this trial
		Fox Chase Cancer Center
		National Cancer Institute (NCI)